Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario, M5S 3G9, Canada.
Cell Calcium. 2013 Mar;53(3):231-40. doi: 10.1016/j.ceca.2012.12.005. Epub 2013 Jan 23.
Several recent reports have demonstrated how engineered proteins can control cell motility, an important functional module for ultimately programming cells as therapeutics. We have reported two engineered proteins that regulate the blebbing cell morphology using chimeras of RhoA, a protein that regulates cytoskeletal tension. Here, we show that engineered switching of blebbing can be used to regulate cell motility. First, the analysis of morphology and motility characteristics showed that blebbing cells wobbled, or shifted, faster and less linearly than cells with a wild type morphology. Second, activating engineered protein switches that regulate cell morphology led to predictable changes in motility characteristics. Last, exogenous stimuli such as blue light, acetylcholine and VEGF-A were used to show that groups of proteins could cooperatively increase cell motility in vitro. This work demonstrates that control of RhoA can program the motility patterns of living cells and has implications in studying the relationship between cell morphology and motility.
最近有几项报告表明,工程蛋白可以控制细胞的运动性,这是将细胞编程为治疗剂的重要功能模块。我们已经报道了两种使用 RhoA(一种调节细胞骨架张力的蛋白质)嵌合体的工程蛋白,它们可以调节起泡细胞的形态。在这里,我们表明起泡的工程开关可以用于调节细胞运动性。首先,形态和运动特性的分析表明,与具有野生型形态的细胞相比,起泡细胞的摆动或移动速度更快,线性度更低。其次,激活调节细胞形态的工程蛋白开关会导致运动特性的可预测变化。最后,使用蓝光、乙酰胆碱和 VEGF-A 等外源刺激来表明,一组蛋白质可以协同增加体外细胞的运动性。这项工作表明,对 RhoA 的控制可以编程活细胞的运动模式,并对研究细胞形态和运动之间的关系具有重要意义。